N. Vogelzang

Evaluating Intermittent Androgen-Deprivation Therapy Phase III Clinical Trials: The Devil Is in the Details.

I. Thompson, C. Tangen, C. Higano, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Novel miRNA-Based Predictive Model for Biochemical Failure Following Post-Prostatectomy Salvage Radiation Therapy

M. Cooperberg, C. Higano, S. Dakhil, 2015 .

Prognostic significance of reverse transcriptase polymerase chain reaction for prostate-specific antigen in men with hormone-refractory prostate cancer.

P. Kantoff, E. Small, D. Hayes, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Use of adrenal androgen levels to predict response to ketoconazole in patients with androgen independent prostate cancer: Results from CALGB 9583.

P. Kantoff, E. Small, C. Ryan, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: Final analysis of a multicentre, open-label, single-arm, phase 2 trial

D. Rasco, C. Aghajanian, M. Brose, 2020, Gynecologic Oncology.

Human gene marker/therapy clinical protocols.

K. Cornetta, J. Roth, R. Crystal, 1996, Human gene therapy.